Procter & Gamble stock jumps after earnings beat and guidance hold

The Procter & Gamble Company (PG) is up 5.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a strong fiscal first-quarter report that came in ahead of expectations and showed broad underlying sales growth. Investors also seem to be responding positively to P&G maintaining its full-year organic sales and earnings outlook while lifting its all-in sales growth range after the Thorne acquisition.

Details:

P&G reported fiscal first-quarter net sales of $23.3 billion, up 4% from a year earlier, with organic sales also up 4%.

Diluted earnings per share rose to $1.97, while core earnings per share reached $2.00, reflecting modest profit growth despite higher operating costs.

P&G raised its fiscal 2027 all-in sales growth outlook to 2% to 4% because of the Thorne deal, but kept its organic sales growth target at 1% to 3% and kept its core EPS growth range in place.

Management described the quarter as a solid start and said the company remains on track for its full-year goals even with ongoing geopolitical and economic pressure.

Sources:

Procter & Gamble Investor Relations, Associated Press

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$PG Insider Trading Activity

$PG insiders have traded $PG stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:

SUSAN STREET WHALEY (Chief Legal Officer & Secy) has made 0 purchases and 3 sales selling 13,251 shares for an estimated $1,910,848.
ANDRE SCHULTEN (Chief Financial Officer) has made 0 purchases and 2 sales selling 9,316 shares for an estimated $1,345,614.
SHAILESH JEJURIKAR (Chairman, President and CEO) sold 6,176 shares for an estimated $888,047
PAUL GAMA (CEO- Health Care) has made 0 purchases and 2 sales selling 5,621 shares for an estimated $811,692.
MARC S. PRITCHARD (Chief Brand Officer) sold 4,030 shares for an estimated $579,473
SUNDAR G. RAMAN (CEO-Fabric Home & Habitat Care) sold 3,435 shares for an estimated $491,273
MOSES VICTOR JAVIER AGUILAR (Chf Rsch, Dev & Innov Officer) sold 3,053 shares for an estimated $438,990
DE AZEVEDO JULIANA MONTEIRO SANTOS (CEO - Grooming) sold 2,368 shares for an estimated $340,494
BALAJI PURUSHOTHAMAN (Chief Human Resources Officer) sold 2,019 shares for an estimated $290,312
EL HAK HESHAM ABD (CEO-Baby and Feminine Care) sold 1,936 shares for an estimated $278,377
MATTHEW W. JANZARUK (SVP - Chief Accounting Officer) has made 0 purchases and 2 sales selling 515 shares for an estimated $74,572.
FREDDY P. BHARUCHA (CEO - Beauty) sold 246 shares for an estimated $35,372

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$PG Hedge Fund Activity

We have seen 1,787 institutional investors add shares of $PG stock to their portfolio, and 1,866 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 47,243,680 shares (+inf%) to their portfolio in Q2 2026, for an estimated $6,927,813,235
JPMORGAN CHASE & CO added 23,668,565 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,470,758,371
CAPITAL WORLD INVESTORS added 7,981,186 shares (+107.3%) to their portfolio in Q2 2026, for an estimated $1,170,361,115
CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 5,883,537 shares (+14.2%) to their portfolio in Q2 2026, for an estimated $862,761,865
SG AMERICAS SECURITIES, LLC added 5,157,503 shares (+573.6%) to their portfolio in Q2 2026, for an estimated $756,296,239
D. E. SHAW & CO., INC. removed 3,612,552 shares (-82.7%) from their portfolio in Q2 2026, for an estimated $529,744,625
PRICE T ROWE ASSOCIATES INC /MD/ removed 3,186,072 shares (-9.9%) from their portfolio in Q2 2026, for an estimated $467,205,598

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$PG Congressional Stock Trading

Members of Congress have traded $PG stock 11 times in the past 6 months. Of those trades, 6 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:

REPRESENTATIVE DAVID TAYLOR has traded it 5 times. They made 4 purchases worth up to $60,000 on 09/08, 08/11, 04/27 and 1 sale worth up to $15,000 on 10/12.
REPRESENTATIVE KEVIN HERN has traded it 2 times. They made 0 purchases and 2 sales worth up to $115,000 on 08/24, 08/05.
REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/17, 05/15 and 0 sales.
REPRESENTATIVE RICHARD MCCORMICK sold up to $15,000 on 07/30.
SENATOR TOMMY TUBERVILLE sold up to $50,000 on 06/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$PG Price Targets

Multiple analysts have issued price targets for $PG recently. We have seen 5 analysts offer price targets for $PG in the last 6 months, with a median target of $162.0.

Here are some recent targets:

Cristian Rios from Bernstein set a target price of $156.0 on 06/11/2026
Robert Ottenstein from Evercore ISI Group set a target price of $162.0 on 04/27/2026
Chris Carey from Wells Fargo set a target price of $164.0 on 04/27/2026
Robert Moskow from TD Cowen set a target price of $150.0 on 04/27/2026
Peter Grom from UBS set a target price of $172.0 on 04/27/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.